Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy
about
Therapy of Liver AbscessesBeta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trialsEpidemiology and outcome of Klebsiella species bloodstream infection: a population-based study.Comparison of strategies using cefpirome and ceftazidime for empiric treatment of pneumonia in intensive care patients. The Cefpirome Pneumonia Study Group.Population pharmacokinetics of ceftizoxime administered by continuous infusion in clinically ill adult patientsTreatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.Should vascular catheters be removed from all patients with candidemia? An evidence-based review.Prognostic factors in severe community-acquired pneumonia in patients without co-morbid illness.Risk factors for toxicity in elderly patients given aminoglycosides once daily.Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis modelIn vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infectionsStenotrophomonas maltophilia Infections in Adults: Primary Bacteremia and Pneumonia.Combination therapy for treatment of infections with gram-negative bacteria.Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections.Klebsiella oxytoca bacteremia causing septic shock in recipients of hematopoietic stem cell transplant: Two case reports.Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamasesBeta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli.Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality.An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).Treatment option for sepsis in children in the era of antibiotic resistance.Klebsiella pneumonia liver abscess syndrome: Case presentation to a college student health clinic.Modeling antibiotic treatment in hospitals: A systematic approach shows benefits of combination therapy over cycling, mixing, and mono-drug therapies.Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage.MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae.Caveolin-1 plays a critical role in host immunity against Klebsiella pneumoniae by regulating STAT5 and Akt activity.Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project.Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremiaProspective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality.Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms.Antibiotic prescribing for ventilator-associated pneumonia: get it right from the beginning but be able to rapidly deescalate.Microbiology in burns patients with blood stream infections: trends over time and during the course of hospitalization.Evaluation of prognostic scoring systems in liver cirrhosis patients with bloodstream infection.Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up.
P2860
Q26796567-C49E7540-8B00-4EFB-9B56-8A56708AFDABQ30756968-EECC7D33-7020-4CC6-9E9F-C35F688EB0A1Q33620388-64B561D8-D483-47C3-B8E8-B753C31C0FB4Q33690393-269851C4-C5CF-44F7-92B4-BFA07C40B845Q33694347-56969711-C052-4AF7-AA1C-B99CBFCC4452Q34327857-1DAB61DD-6C1E-4A12-A454-4036901ED2C7Q34505632-452FC485-DD46-4970-963A-952E72979F90Q34530347-1882E299-24DF-4C41-81EF-11241CE21CDBQ34752229-4DCF63F8-81E7-42AD-B660-D93FDD693599Q35109053-50581EF4-742F-48D3-B61C-155E2AC7533CQ35122321-D28BB8D7-CEF8-4E82-AAFC-1F868DBAFD47Q35136181-C945A364-9051-47CB-B6B9-7D1DDDC691CCQ35230821-E5B1753B-5F22-4290-B383-7DAEB12E1F11Q36147564-1E64CA23-0214-4241-9DA5-DDA278E4789AQ36156077-B99E4652-A48B-4AEB-9F43-27B95F00F4EAQ36837889-07E21173-3FAB-4FEB-ABE0-D347A47CE4DBQ36916065-81F1E2E0-6C94-467F-91CF-B874E73DE2ECQ36933469-1B364C5F-0316-4499-ABDB-F46F36ED3040Q37032869-FCD21337-23E3-45CB-8E1E-BD86BC3A73B7Q37144870-66A462B8-FEE9-48DF-9CBB-4C1877605065Q37292252-8351AB62-5A6E-48A7-932A-6C4AA57D6527Q37422089-50F00BB4-0488-4FEB-AD4B-390119304C8CQ37563029-5053F45A-7597-48A1-AEA7-7D794F15DC5BQ38070006-DC137427-AAFE-47B9-8341-5846ED488E4EQ38246118-869B8C6E-4BE4-4B8D-89C4-D2A87D18C9ACQ38954431-65EA7803-1A5A-4BC8-BDED-27CAB1BB2FCCQ40043861-57A5D8EF-C463-4F2E-89CE-0C867D63D8F5Q40285446-49F73256-BE21-4758-AFB3-5CF1367E55CAQ40369820-C3B07F8E-6ABC-4CDD-8314-454A2687ECC7Q40419134-55424AA0-8041-40D6-9DDF-7A28F19101CAQ40922179-1A024A89-EE47-43D2-978F-E853B3B0227AQ41587703-883ADD36-A3F1-4FF2-9AE3-0EC07C337880Q42537148-15A2CA03-A11A-40BC-9E95-8DDA4E0B18B5Q43692504-29F6FF31-AA91-4291-B323-9E22003CC109Q44943295-AB31BBE8-9441-4D80-824F-9CE896719F4CQ46532816-FEEC2370-4DF4-4D9F-8DB5-EA80B8528031Q47731374-2D9C9E90-BE6B-428F-B918-ABFE4CF8A900Q48361500-910E5BB8-31DB-4E33-AEAA-52DB8311BD49Q48508694-B1661050-6BBC-4B8C-9625-CE69C4F5D5A1Q50061211-A87FA3F3-2054-4951-8C7E-455C56474D34
P2860
Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Prospective observational stud ...... ombinations versus monotherapy
@ast
Prospective observational stud ...... ombinations versus monotherapy
@en
type
label
Prospective observational stud ...... ombinations versus monotherapy
@ast
Prospective observational stud ...... ombinations versus monotherapy
@en
prefLabel
Prospective observational stud ...... ombinations versus monotherapy
@ast
Prospective observational stud ...... ombinations versus monotherapy
@en
P2093
P2860
P356
P1476
Prospective observational stud ...... ombinations versus monotherapy
@en
P2093
Beam TR Jr
Gerding DN
Korvick JA
Schenfeld L
Wagener MM
Weinbaum D
P2860
P304
P356
10.1128/AAC.36.12.2639
P407
P577
1992-12-01T00:00:00Z